Neuroethics is a multidisciplinary field that explores the ethical, legal, and social implications of advances in neuroscience. At its core, neuroethics seeks to address the moral questions raised by our increasing understanding of the brain and its implications for society. This field emerged in response to rapid advancements in neurotechnology, such as brain imaging techniques and cognitive enhancement methods, which have profound implications for individual autonomy, privacy, and identity. One key area of concern in neuroethics is the use of neuroscientific findings in legal and moral decision-making. As neuroscience sheds light on the biological underpinnings of human behavior, questions arise about how this knowledge should influence concepts such as criminal responsibility and moral culpability. For instance, should individuals with certain neurological conditions be held accountable for their actions to the same extent as those without such conditions? Neuroethicists grapple with these questions to ensure that legal systems are fair and just in light of neuroscientific evidence. Another important aspect of neuroethics involves the responsible use of neurotechnology in medical and non-medical contexts. For example, brain-computer interfaces (BCIs) hold promise for restoring mobility to individuals with paralysis, but they also raise concerns about privacy and potential misuse. Ethical considerations must be carefully weighed to balance the benefits of such technologies with their potential risks and unintended consequences. Additionally, neuroethics delves into issues surrounding cognitive enhancement, such as the use of pharmaceuticals or brain stimulation techniques to boost cognitive abilities. While these interventions may offer benefits for individuals with cognitive impairments, they also raise questions about fairness, equality, and the authenticity of human experience. Ethicists seek to establish guidelines for the responsible development and use of cognitive enhancement technologies to ensure equitable access and minimize potential harms.
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Study of resilience in cases of incest, father-daughter, step-father and step-daughter in the pre-pubber and puberous period among adult women and mothers: How to overcome the traumatisms of an incestuous relationship?
Daniele Lapointe, Laval University, Canada
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom